An online solution focused brief therapy for adolescent anxiety during the novel coronavirus disease (COVID-19) pandemic: a structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-05-132022-10-29 Journal: Trials [Category] Coronavirus, MERS, SARS, [키워드] Adolescent adolescents Anxiety anxiety symptom assigned Beijing Chinese Clinical outcome collected Controlled trial Coping strategy counseling COVID-19 COVID-19 outbreak COVID-19 pandemic criteria Depression Diagnosis disorder distress Effectiveness Enrollment exclusion criteria faculty GAD Generalized ideation inclusion criteria intervention group Juan medication mental health normal novel coronavirus disease objective open label participant presenting protocol Psychiatric Psychology randomised controlled trial Randomized Randomized controlled trial Randomly receive receiving Reporting solution Solution focused brief therapy Study protocol Taking therapy university Unwilling [DOI] 10.1186/s13063-020-04355-6 PMC 바로가기 [Article Type] Letter
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2Brief Report Published on 2020-05-092022-10-31 Journal: Nutrients [Category] COVID-19, MERS, SARS, [키워드] 25-hydroxyvitamin D acute respiratory syndrome age cause Clinical outcome Cohort cohort of patient Concentration concentrations conducted Controlled trial coronavirus coronavirus disease COVID-19 death deficiency develop evaluate investigated Lower median value Mild observation Patient PCR PCR-positive plasma recommendation reduce reducing risk risk of infection SARS-CoV-2 severe symptoms significantly lower suggested Switzerland Vitamin D Vitamin D supplementation [DOI] 10.3390/nu12051359 PMC 바로가기 [Article Type] Brief Report
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and DeathsReview Published on 2020-04-022022-10-30 Journal: Nutrients [Category] COVID-19, SARS, [키워드] 25-hydroxyvitamin D acute respiratory distress acute respiratory distress syndrome (ARDS) addition age anti-inflammatory cytokines ascorbic acid Cathelicidin chronic disease clinical trial Comorbidity Concentration concentrations conducted contribute Controlled trial coronavirus COVID-19 COVID-19 pandemic Cytokine storm death deficiency dose Epidemiology evaluate Health include infected with COVID-19 Inflammation Influenza knowledge Lungs measure mechanism mechanisms Observational observational study occurred outbreak Pneumonia prevention pro-inflammatory cytokine Public quarantine raise recommendations reduce reduced reducing reported respiratory tract infection Respiratory tract infections risk risk of COVID-19 risk of infection risk of infections solar radiation southern hemisphere Treatment UVB viral replication Vitamin C Vitamin D Vitamin D supplementation [DOI] 10.3390/nu12040988 PMC 바로가기 [Article Type] Review
Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trialHIV에 감염된 임산부에서 3가 비활성화 인플루엔자 백신의 다양한 투여 일정의 면역원성과 안전성: 무작위 대조 시험Article Published on 2020-01-032022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] age All participants analysed Antenatal Antibody Response assigned Birth clinics completion computer-generated Controlled trial dose dosing schedule double-blind eligible ENhance enrolled enrolment estimated gestational age except for Final finding foundation Frequency funding gestational age greater group Group allocation HIV immunogenic immunogenicity Immunogenicity analyses immunogenicity analysis inactivated induce Infant Infants Influenza influenza vaccine Local Melinda Gate Melinda Gates mother Neonates Newborn newborn infants outcome participant pregnant women protective antibodies Protective antibody randomisation list randomised randomised controlled trial Randomly reaction receive recipient recipients recruited regimen Registered Safety Seasonal influenza seroconversion rate seroconversion rates Seven significantly higher single dose Single-dose South Africa Standard-dose strain Strains systemic reactions the vaccine three groups transfer trivalent Vaccine vaccine dose were measured with HIV women [DOI] 10.1016/S2352-3018(19)30322-4 PMC 바로가기 [Article Type] Article
COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trialDEXamethasone(CoDEX)으로 치료된 COVID-19 관련 ARDS: 무작위 시험에 대한 연구 설계 및 근거Original Article Published on 2020-01-012022-08-13 Journal: Revista Brasileira de Terapia Intensiva [Category] 임상, [키워드] 350 patient 350 patients 48 hour 48 hours 6-level ordinal scale acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration Adrenal cortex hormones Adult patients all-cause mortality rate all-cause mortality rates assessment Berlin criteria caused clinical status clinical trial Control control group Controlled trial coronavirus coronavirus disease Coronavirus disease 2019 coronavirus disease 2019 - COVID-19 Corticosteroid Corticosteroides Corticosteroids COVID-19 COVID-19-associated ARDS Cuidados críticos days alive defined develop Dexametasona Dexamethasone dexamethasone 10mg IV dexamethasone 20mg intravenous early-onset Effectiveness Eligible patients evaluate evaluated failure followed by group hospitalized patient hospitalized patients Infection intensive care intervention group intravenous Invasive mechanical ventilation less mechanical ventilation mechanical ventilation duration moderate mortality rates multicenter Non-COVID-19 non-COVID-19 acute respiratory distress syndrome objective occur once daily Open-label Ordinal Scale outcome pandemic Patient patients with moderate Pneumonia Pragmatic Primary outcome randomization Randomized randomized trial Randomly receive respiratory respiratory compromise respiratory distress Respiratory distress syndrome Respiratory distress syndrome, adult Síndrome do desconforto respiratório do adulto SARS-CoV-2 SARS-COV-2 infection score secondary Secondary outcomes severe acute respiratory syndrome Coronavirus Spread standard treatment stratified Study design syndrome treated Trial unit discharge ventilator-free day Ventilator-free days Viral Viral pneumonia [DOI] 10.5935/0103-507X.20200063 PMC 바로가기 [Article Type] Original Article
Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial말라위에서 고위험 조건 및 중증 폐렴이 있는 어린이를 위한 버블 연속 기도 양압: 공개 라벨, 무작위, 대조 시험Article Published on 2019-11-012022-09-06 Journal: The Lancet. Respiratory Medicine [Category] Communicable Disease, [키워드] 1:1 95% CI Administered adverse event adverse events African AIDS Analysis Antibiotics assigned Care cause of death children condition Controlled trial country death did not reduce died District eligibility Empowering enrolled event finding Follow-up foundation funding futility HIV infection hospital Hospital mortality hospitalisation hypoxaemia implementation IMPROVE Infection intention-to-treat less Malnutrition Melinda Gate Melinda Gates monitoring board Mortality MOST nares nasal nasal cannula occur occurred open label Open-label outcome oxygen oxygen saturation participant Patient patient population per protocol Pneumonia Pneumothorax positive airway pressure Primary outcome randomised Randomly receiving Registered Relative risk risk Safe screened severe malnutrition severe pneumonia Society survival Suspected Treatment Trial Ventilation was done with HIV [DOI] 10.1016/S2213-2600(19)30243-7 PMC 바로가기 [Article Type] Article
Economic incentives for HIV testing by adolescents in Zimbabwe: a randomised controlled trial짐바브웨 청소년의 HIV 검사에 대한 경제적 인센티브: 무작위 대조 시험Article Published on 2017-11-202022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] 95% CI adjusted odds ratio Adults adverse event adverse events African Analysis Antiretroviral therapy assigned assistant blinded Care Caregivers children clinical Community Consent Controlled trial Coverage Effect eligible enrolled enrolment finding fixed funding group had no health-care HIV HIV infection HIV testing household Households Intention intention to treat investigated Local Logistic regression much lower not blinded number of children Older outcome Pan Pan African Clinical Trials Registry participant Prevalence prevention service Primary outcome proportion provided random effect randomised controlled trial Randomly receive Registered registry repeated reported Research statistician tested Trial Wellcome Trust Zimbabwe [DOI] 10.1016/S2352-3018(17)30176-5 PMC 바로가기 [Article Type] Article
A cluster randomized controlled trial to increase the availability and acceptability of voluntary medical male circumcision in Zambia: The Spear and Shield Project잠비아에서 자발적인 의료 남성 할례의 가용성과 수용 가능성을 높이기 위한 클러스터 무작위 대조 시험: The Spear and Shield ProjectArticle Published on 2015-06-172022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] 95% CI adjusted odds ratio adverse event adverse events assigned baseline Care center Cluster community health Community health centers conditions conducted Control Controlled trial counseling death expressed female finding funding Health Health care HIV HIV infection HIV prevention Intervention likelihood male men MOST Odds ratio participant Participants Participation Patient performed post-intervention Prevalence prevention programs Primary outcome randomization Randomized controlled trial Randomly reported Result Shield significant increase Spear statistician stratified study participation supply Support tested Trial registration [DOI] 10.1016/S2352-3018(15)00042-9 PMC 바로가기 [Article Type] Article
Findings from the SASA! Study: a cluster randomized controlled trial to assess the impact of a community mobilization intervention to prevent violence against women and reduce HIV risk in Kampala, UgandaSASA의 발견! 연구: 우간다 캄팔라에서 여성에 대한 폭력을 예방하고 HIV 위험을 줄이기 위한 지역사회 동원 개입의 영향을 평가하기 위한 클러스터 무작위 통제 시험Research Article Published on 2014-07-312022-08-09 Journal: BMC Medicine [Category] 임상, [키워드] 95% CI 95% confidence interval adjusted baseline Cluster Community Community mobilization conducted Controlled trial Cross-sectional surveys defined Drivers East Africa eight Evidence finding Follow-up Gender based violence greater HIV Impact evaluation impacts implementation intention-to-treat analysis Intervention Intimate partner violence men outcome physical post intervention Prevalence Prevent Primary outcome protocol public health random Random sample Randomized controlled trial receive reduce replicated responses Result risk risk ratio Sex significantly significantly lower Study protocol sub-Saharan Africa supplementary material Trial registration Uganda Violence Violence prevention while woman women [DOI] 10.1186/s12916-014-0122-5 PMC 바로가기 [Article Type] Research Article